A Case Report: Ayurvedic Management of DMD w.s.r to Mamsagata-Vata

Authors

  • Mridula Assistant Professor, Dept. Of Kayachikitsa; SBSJSAMC & H, Farrukhabad (U.P) Author
  • Preetimayee Sahoo Assistant Professor, Dept. Of Kayachikitsa; SBSJSAMC & H, Farrukhabad (U.P) Author
  • Nihar Ranjan Mahanta Assistant Professor, Dept. Of Panchakarma; SBSJSAMC & H, Farrukhabad (U.P) Author

DOI:

https://doi.org/10.48165/

Keywords:

Duchenne Muscular Dystrophy, Mamsagata-vata, Mashapinda-sveda, Panchatikta-Ghrita

Abstract

Duchenne Muscular Dystrophy (DMD) describes generalized progressive muscular  weakness due to the wasting of muscle fibres. It is the most widespread lethal genetic  disease of humans. The progression is affected by known immunological and  mechanical factors, and possibly other unknown mechanisms. Sufferers become  increasingly disabled as the disease progresses & caring for the affected child in  resource poor settings face a lot challenges. DMD have a lack of effective treatment.  Glucocorticoids are the standard of care in DMD until now and its long term use are  not devoid from crucial complications mainly in long term use like poor bone health,  obesity, neurologic impairments, cardiac & respiratory problems. Hence, an  alternative therapy is needed. Thus, case study was conducted considering DMD as  Mamsagata-vata and Ayurvedic management Niruha Basti having Panchatikta ghrita, Mashapinda-sveda was planned accordingly. During & after treatment, a  positive outcome in mobility & self-care was noted

Downloads

Download data is not yet available.

References

Acharya YT, Sushruta Samhita, with Dalhanacharya. NibandhaSangraha, Commentary. Reprint ed. Varanasi: ChaukhambhaOrientalia; 2009. p. 113-114.

Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1:

diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77–93.

Griggs RC, Moxley RT, 3rd, Mendell JR, et al. Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months) Neurology. 1993;43:520–527.

Quinlivan R, Roper H, Davie M, et al. Report of Muscular Dystrophy Campaign funded workshop Birmingham, UK, Januar 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention. NeuromusculDisord. 2005;15:72–79

Acharya YT Charaka Samhita, with Chakrapaanidatta. Ayurved Dipika, Commentary. Reprint ed. Varanasi: Chaukhambha Orientalia; 2009. pp. 620

Downloads

Published

2024-03-28

How to Cite

Mridula, Sahoo, P., & Mahanta, N.R. (2024). A Case Report: Ayurvedic Management of DMD w.s.r to Mamsagata-Vata. International Research Journal of Ayurveda and Yoga, 4(12), 41–45. https://doi.org/10.48165/